R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine

Endothelial progenitor cells (EPCs) have been isolated and shown to be effective in animal models of ischemia, and many groups involved in clinical trials have demonstrated that EPC therapy is safe and feasible for the treatment of critical limb ischemia and cardiovascular diseases. However, many issues in the field of EPC biology, especially in regards to the proper and unambiguous molecular characterization of these cells still remain unresolved, hampering not only basic research but also the effective therapeutic use and widespread application of these cells. In this review, we introduce the recent concept of EPC identification in terms of hematopoietic and nonhematopoietic EPCs along with the development of EPC biology research. Furthermore, we define the role of circulating EPCs in postnatal neovascularization to illustrate the future direction of EPC therapeutic applications. Next, we review on‐going medical applications of EPC for cardiovascular and peripheral vascular diseases, introduce the practical example of therapeutic application of EPCs to patients with ischemic disease, and discuss about the feedback of clinical researches. STEM CELLS 2011;29:1650–1655

[1]  M. Kurosaka,et al.  Local Transplantation of G-CSF-Mobilized CD34+ Cells in a Patient with Tibial Nonunion: A Case Report , 2011, Cell transplantation.

[2]  H. Masuda,et al.  Methodological Development of a Clonogenic Assay to Determine Endothelial Progenitor Cell Potential , 2011, Circulation research.

[3]  S. Nishikawa,et al.  Lnk Deletion Reinforces the Function of Bone Marrow Progenitors in Promoting Neovascularization and Astrogliosis Following Spinal Cord Injury , 2009, Stem cells.

[4]  A. Testori,et al.  Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia , 2010, Bone Marrow Transplantation.

[5]  T. Yamanaka,et al.  Intramuscular Transplantation of G‐CSF‐Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single‐Blinded, Dose‐Escalation Clinical Trial , 2009, Stem cells.

[6]  S. Hsu,et al.  Transplantation of Endothelial Progenitor Cells as Therapeutics for Cardiovascular Diseases , 2009, Cell transplantation.

[7]  R. Kishore,et al.  A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[8]  F. Timmermans,et al.  Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.

[9]  Douglas Losordo,et al.  Endothelial progenitor cells in neovascularization of infarcted myocardium. , 2008, Journal of molecular and cellular cardiology.

[10]  H. Masuda,et al.  Specific Jagged-1 Signal From Bone Marrow Microenvironment Is Required for Endothelial Progenitor Cell Development for Neovascularization , 2008, Circulation.

[11]  S. Warren,et al.  The Effects of Flap Ischemia on Normal and Diabetic Progenitor Cell Function , 2008, Plastic and reconstructive surgery.

[12]  H. Haider,et al.  Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. , 2008, Journal of molecular and cellular cardiology.

[13]  D. Celermajer,et al.  Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. , 2008, Journal of the American College of Cardiology.

[14]  H. Akimaru,et al.  Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. , 2007, Journal of molecular and cellular cardiology.

[15]  Ju-Young Kim,et al.  Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.

[16]  H. Masuda,et al.  Estrogen-Mediated Endothelial Progenitor Cell Biology and Kinetics For Physiological Postnatal Vasculogenesis , 2007, Circulation research.

[17]  R. Raedt,et al.  Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[18]  K. Poh,et al.  Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.

[19]  M. Tendera,et al.  Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? , 2007, Heart.

[20]  C. Heeschen,et al.  Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia , 2007, Circulation research.

[21]  Gustav Steinhoff,et al.  Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. , 2007, The Journal of thoracic and cardiovascular surgery.

[22]  Z. Ming,et al.  The clinical study of autologous peripheral blood stem cell transplantation by intracoronory infusion in patients with acute myocardial infarction (AMI) , 2007 .

[23]  Y. Liu,et al.  The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). , 2007, International journal of cardiology.

[24]  K. Trinkaus,et al.  Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. , 2006, Blood.

[25]  T. Asahara,et al.  CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.

[26]  M. Wong,et al.  Myeloid lineage progenitors give rise to vascular endothelium , 2006, Proceedings of the National Academy of Sciences.

[27]  V. Dzau,et al.  Essential Role of ICAM-1/CD18 in Mediating EPC Recruitment, Angiogenesis, and Repair to the Infarcted Myocardium , 2006, Circulation research.

[28]  A. Rivard,et al.  Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. , 2006, Atherosclerosis.

[29]  J. Price,et al.  The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells. , 2006, The American journal of pathology.

[30]  R. Whitbourn,et al.  Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. , 2006, International journal of cardiology.

[31]  H. Masuda,et al.  Estradiol Enhances Recovery After Myocardial Infarction by Augmenting Incorporation of Bone Marrow–Derived Endothelial Progenitor Cells Into Sites of Ischemia-Induced Neovascularization via Endothelial Nitric Oxide Synthase–Mediated Activation of Matrix Metalloproteinase-9 , 2006, Circulation.

[32]  K. Maruyama,et al.  Endothelial Progenitor Thrombospondin-1 Mediates Diabetes-Induced Delay in Reendothelialization Following Arterial Injury , 2006, Circulation research.

[33]  T. Asahara,et al.  Dose-Dependent Contribution of CD34-Positive Cell Transplantation to Concurrent Vasculogenesis and Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction , 2006, Circulation.

[34]  M. Putt,et al.  The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. , 2006, Journal of vascular surgery.

[35]  C. Heeschen,et al.  Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. , 2005, Journal of molecular and cellular cardiology.

[36]  T. Imanishi,et al.  Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension , 2005, Journal of hypertension.

[37]  M. Yoder,et al.  Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.

[38]  W. Wijns,et al.  Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety , 2005, Circulation.

[39]  A. Scheffold,et al.  CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors , 2005, Circulation research.

[40]  K. Götze,et al.  Endothelial‐like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  M. Kelm,et al.  Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.

[42]  T. Asahara,et al.  Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity , 2005, Circulation.

[43]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[44]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[45]  M. Hayashi,et al.  Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[46]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[47]  M. Wong,et al.  Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. , 2004, Blood.

[48]  M. Pesce,et al.  Differentiation of Human Umbilical Cord Blood – Derived Stem Cells in Ischemic Limb Tissues , 2003 .

[49]  R. Vile,et al.  Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood , 2003, Circulation research.

[50]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[51]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[52]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[53]  C. Peschle,et al.  Identification of the hemangioblast in postnatal life. , 2002 .

[54]  T. Asahara,et al.  Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. , 2002, Experimental hematology.

[55]  T. Asahara,et al.  Transplantation of endothelial progenitor cells for therapeutic neovascularization. , 2002, Cardiovascular radiation medicine.

[56]  E. Scott,et al.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.

[57]  N. Moldovan.  Role of monocytes and macrophages in adult angiogenesis: a light at the tunnel's end. , 2002, Journal of hematotherapy & stem cell research.

[58]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[59]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[60]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[61]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[62]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[63]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[64]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[66]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[67]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[68]  J. Isner,et al.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.

[69]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[70]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[71]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[72]  W. Risau,et al.  Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.

[73]  T. Doetschman,et al.  Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. , 1988, Development.